ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,803Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 3593

$1.63M Total Retail Price of All Prescriptions

Rank: 38 out of 3593

714 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 714 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 714 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 28,171 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 1,050 987 1 4
WARFARIN SODIUM 1,017 1,017 2 18
SIMVASTATIN 884 848 3 1
FUROSEMIDE 882 843 4 9
LISINOPRIL 856 800 5 2
AMLODIPINE BESYLATE 767 751 6 3
METOPROLOL TARTRATE 667 646 7 8
OMEPRAZOLE 664 633 8 5
NAMENDA 660 652 9 50
POLYETHYLENE GLYCOL 3350 634 623 10 143
SPIRONOLACTONE 575 530 11 86
CITALOPRAM HBR 531 497 12 25
HYDROCODONE-ACETAMINOPHEN 527 475 S3 13 7
TRAZODONE HCL 486 461 14 53
POTASSIUM CHLORIDE 486 452 14 24
DONEPEZIL HCL 442 442 16 31
MIRTAZAPINE 438 410 17 64
GABAPENTIN 437 422 18 16
VENLAFAXINE HCL ER 350 347 19 178
ESCITALOPRAM OXALATE 337 321 20 71
QUETIAPINE FUMARATE 325 267 21 89
CARVEDILOL 312 309 22 23
LEVETIRACETAM 294 246 23 127
LANTUS 280 247 24 57
NYSTATIN 279 277 25 167
METFORMIN HCL 279 266 25 6
AZITHROMYCIN 266 246 27 34
CLONIDINE HCL 251 250 28 41
CIPROFLOXACIN HCL 242 239 29 52
CYMBALTA 235 213 30 73
METOPROLOL SUCCINATE 232 226 31 19
DIGOXIN 232 232 31 58
PREDNISONE 222 222 33 49
TRAMADOL HCL 218 204 34 17
ZOLPIDEM TARTRATE 217 197 35 12
SERTRALINE HCL 213 204 36 28
CLOPIDOGREL 202 194 37 30
PRAVASTATIN SODIUM 202 190 37 13
NOVOLIN R 201 189 39 140
EXELON 195 195 40 123
ISOSORBIDE MONONITRATE ER 185 179 41 61
IPRATROPIUM-ALBUTEROL 182 181 42 154
HYDROCHLOROTHIAZIDE 165 162 43 10
LIDODERM 160 160 44 78
SEROQUEL 153 130 45 172
DIVALPROEX SODIUM 150 114 46 121
PLAVIX 150 141 46 42
OLANZAPINE 142 138 48 198
RISPERIDONE 141 137 49 83
PANTOPRAZOLE SODIUM 139 136 50 45
JANUVIA 138 126 51 81
RAMIPRIL 137 137 52 92
ATORVASTATIN CALCIUM 136 129 53 15
VENLAFAXINE HCL 134 134 54 267
TRAMADOL HCL-ACETAMINOPHEN 133 133 55 147
ALLOPURINOL 131 117 56 35
LEVOFLOXACIN 127 126 57 116
LOSARTAN POTASSIUM 124 116 58 14
ATENOLOL 123 121 59 11
TAMSULOSIN HCL 122 112 60 33
DOXYCYCLINE HYCLATE 118 118 61 141
NOVOLOG 113 87 62 134
CEPHALEXIN 112 105 63 150
CARBIDOPA-LEVODOPA 110 110 64 135
FAMOTIDINE 104 104 65 70
HYDRALAZINE HCL 98 88 66 107
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 89 67 102
FLUOXETINE HCL 93 65 68 60
NEXIUM 92 87 69 36
LATANOPROST 90 90 70 195
LEXAPRO 88 83 71 184
KETOCONAZOLE 87 81 72 118
METOCLOPRAMIDE HCL 86 79 73 145
TRIAMTERENE-HCTZ 84 77 74 66
GLIPIZIDE 83 67 75 40
CARAFATE 77 77 76 427
LOVASTATIN 75 70 77 20
TIMOLOL MALEATE 74 74 78 295
FLUTICASONE PROPIONATE 74 74 78 32
RANITIDINE HCL 72 72 80 27
SYNTHROID 69 66 81 51
PRAMIPEXOLE DIHYDROCHLORIDE 68 68 82 308
ALENDRONATE SODIUM 67 66 83 22
LACTULOSE 67 66 83 126
DORZOLAMIDE-TIMOLOL 66 66 85 415
AMITIZA 66 61 85 349
ROPINIROLE HCL 66 64 85 144
SPIRIVA 65 65 88 87
SANTYL 65 61 88 208
LYRICA 65 45 88 105
BUSPIRONE HCL 64 60 91 156
BISOPROLOL FUMARATE 63 63 92 265
TERAZOSIN HCL 63 63 92 115
MUPIROCIN 63 57 92 132
CRESTOR 63 46 92 21
SEROQUEL XR 62 37 96 199
GLIPIZIDE ER 61 57 97 101
TRIAMCINOLONE ACETONIDE 60 52 98 119
FLUCONAZOLE 60 59 98 229
SINGULAIR 57 57 100 77
LUMIGAN 57 57 100 333
CLONIDINE 57 56 100 346
TRIMETHOPRIM 57 57 100 574
NITROGLYCERIN PATCH 56 56 104 212
NUEDEXTA 54 54 105 439
LOSARTAN-HYDROCHLOROTHIAZIDE 54 50 105 48
MONUROL 54 54 10 105 584
ALBUTEROL SULFATE 53 52 108 157
DIOVAN 52 52 109 46
METOLAZONE 51 51 110 254
DETROL LA 50 50 111 262
DILTIAZEM 24HR CD 50 50 111 173
HYDROCORTISONE 50 50 111 273
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.